Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Aletaha

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
What should be our treatment goal in rheumatoid arthritis today?J S Smolen, D Aletaha
Zeitschrift Fur Rheumatologie|February 24, 2006
[Measuring disease activity for rheumatoid arthritis]D Aletaha, T Stamm, J Smolen
Annals of the Rheumatic Diseases|April 16, 2003
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritisD Aletaha, T Kapral, J S Smolen
Annals of the Rheumatic Diseases|January 14, 2009
Does damage cause inflammation? Revisiting the link between joint damage and inflammationJ S Smolen, D Aletaha, G Steiner
Clinical and Experimental Rheumatology|November 21, 2007
Disease activity measures for rheumatoid arthritisM Dougados, D Aletaha, P van Riel
Annals of the Rheumatic Diseases|July 27, 2016
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progressionD Aletaha, F Alasti, J S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
Complexities in defining remission in rheumatic diseasesT Pincus, A Kavanaugh, D Aletaha, et al.
Arthritis Research & Therapy|July 6, 2017
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibitionM Schoels, F Alasti, J S Smolen, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
What should be our treatment goal in rheumatoid arthritis today?J S Smolen, D Aletaha
Zeitschrift Fur Rheumatologie|February 24, 2006
[Measuring disease activity for rheumatoid arthritis]D Aletaha, T Stamm, J Smolen
Annals of the Rheumatic Diseases|April 16, 2003
Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritisD Aletaha, T Kapral, J S Smolen
Annals of the Rheumatic Diseases|January 14, 2009
Does damage cause inflammation? Revisiting the link between joint damage and inflammationJ S Smolen, D Aletaha, G Steiner
Clinical and Experimental Rheumatology|November 21, 2007
Disease activity measures for rheumatoid arthritisM Dougados, D Aletaha, P van Riel
Annals of the Rheumatic Diseases|July 27, 2016
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progressionD Aletaha, F Alasti, J S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
Complexities in defining remission in rheumatic diseasesT Pincus, A Kavanaugh, D Aletaha, et al.
Arthritis Research & Therapy|July 6, 2017
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibitionM Schoels, F Alasti, J S Smolen, et al.
Pageof 6